Skip to main content
Caplight Logo









FathomX

FathomX

Private
SingaporeHealthcare & Life Scienceshttps://fathomx.co

Last Round

Seed

Sep 1, 2022

Total Funding Raised

$3.95M

Company Overview

FathomX operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Seed round in September 2022.

FathomX is a medtech company that provides an artificial intelligence-driven platform for breast cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

FathomX Comparables

Compare FathomX with similar companies based on industry and business-model similarity.

FathomX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ScreenPoint Medical
89%
Clairity, Inc.
84%
b-rayZ AG
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

FathomX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2022
SeedAug 1, 2022
SeedApr 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Hao Du

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

FathomX Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 526% MoM, from 39 to 244.

  • Aug 1, 2022

    $2M raised in Seed round.

Book a demo to see all signals

For institutional investors. Book with your work email.

FathomX Filings

Explore SEC and related filing metadata, where available.

FathomX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about FathomX's valuation, stock price, and market status.

Is FathomX a public or private company?

FathomX is a private company.

What is the current stock price of FathomX?

FathomX is a private company, so its shares have no public market price. Caplight tracks FathomX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is FathomX worth (valuation)?

Valuation information for FathomX is not publicly available.

Can I buy FathomX stock?

FathomX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was FathomX's last funding round?

FathomX's most recent funding round was Seed on September 1, 2022.

Who are the main investors in FathomX?

Key investors in FathomX include Startup SG, Singapore-MIT Alliance for Research and Technology Centre (SMART), SMART Innovation Centre.

Will FathomX IPO soon?

No public IPO plans have been announced for FathomX.

How can I track FathomX secondary market activity?

Caplight tracks bids, offers, and trades in FathomX's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range6
Year Founded2019
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?